On Wednesday, July 6th, SwedenBIO arranges a seminar on the subject: The return of the factories – This is how Sweden wins the battle for the future pharmaceutical production.
The government has initiated a new industrial and export strategy, but is this enough in order to make Sweden a global leader within life science production and to continue to generate multi billion worth of export incomes? Pharmaceuticals, biotechnology and medical technology already contributes to Sweden’s largest export incomes, after paper, and the new investments that are being made brings hope of an even larger export and more job openings. But according to SwedenBIO the success is far from secured in a global industry where the decisions are taken far beyond the borders of Sweden.
During the seminar factory managers and decision makers are gathered to discuss this hot topic. Among the participants are for example Oscar Stenström, the state secretary for Sweden’s Trade Minister Ann Linde, Jan Erneberg, General Manager of GE Healthcare Global Supply Chain, Margareta Ozolins, VP Sweden Operations at AstraZenecaäs factories in Södertälje, Kirsti Gjellan, Head of Biologics Development and Supply at Sobi, Christopher Siegmund, Area Manager at Pfizer’s Strängnäs factory and Carl-Johan Sundberg, board member of Cobra Biologics and professor at Karolinska Institutet.
The seminar takes place Wednesday July 6th 10:00 – 11:00 AM at Volters gränd 8 in Visby.
Photo: Oscar Stenström, Margareta Ozolins, Christopher Siegmund, Kirsti Gjellan, Jan Erneberg and Carl-Johan Sundberg.
